Introduction
The novel corona virus commonly known as COVID-19 has caused global
pandemic. As of April 9th, more than 1.65 million individuals are
affected with a death rate of 6% [1]. However, not many cases of
serious COVID-19 cases have been reported in children. Angiotensin
converting enzyme II (ACE2) is the likely receptor for COVID-19. There
is speculation that children may have decreased binding ability to ACE2
as maturity and function is lower. This may explain the lower severity
in children. CF is an autosomal-recessive genetic disease. There have
not been any case reports of individuals with CF and COVID-19 [2].
Here, we present a case of an infant with CF who recovered from COVID-19
infection after treatment with hydroxychloroquine and inhaled hypertonic
saline.